Mesoblast (MESO) Amortizatization of Intangibles (2019 - 2023)
Mesoblast's (MESO) quarterly Amortizatization of Intangibles came in at -$394000.0 in Q1 2023, up 10.86% year-on-year from -$355404.1 in Q1 2022, and up 11.26% quarter-over-quarter from -$444000.0 in Q4 2022.
Mesoblast (MESO) Amortizatization of Intangibles (2019 - 2023) Analysis & Trends
Mesoblast has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting -$394000.0 for Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -394,000.00 |
| Mar 31, 2023 | -394,000.00 |
| Dec 31, 2022 | -444,000.00 |
| Dec 31, 2022 | -444,000.00 |
| Sep 30, 2022 | -432,000.00 |
| Sep 30, 2022 | -432,000.00 |
| Mar 31, 2022 | -442,000.00 |
| Mar 31, 2022 | -442,000.00 |
| Dec 31, 2021 | -430,000.00 |
| Dec 31, 2021 | -430,000.00 |
| Sep 30, 2021 | -410,000.00 |
| Sep 30, 2021 | -410,000.00 |
| Mar 31, 2021 | -410,000.00 |
| Mar 31, 2021 | -410,000.00 |
| Dec 31, 2020 | -430,000.00 |
| Dec 31, 2020 | -430,000.00 |
| Sep 30, 2020 | -409,000.00 |
| Sep 30, 2020 | -409,000.00 |
| Mar 31, 2020 | -395,000.00 |
| Mar 31, 2020 | -395,000.00 |